Reuters logo
3 个月前
BRIEF-Molecular Partners: partner Allergan completes patient recruitment in both abicipar pegol nAMD Phase 3 studies
2017年5月9日 / 凌晨5点13分 / 3 个月前

BRIEF-Molecular Partners: partner Allergan completes patient recruitment in both abicipar pegol nAMD Phase 3 studies

May 9 (Reuters) - MOLECULAR PARTNERS AG

* STRATEGIC PARTNER ALLERGAN COMPLETED PATIENT RECRUITMENT IN BOTH ABICIPAR PEGOL NAMD PHASE 3 STUDIES

* TOP-LINE DATA ARE EXPECTED IN 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below